SCHEMBL6024418

SCHEMBL6024418

CCCN(CCC)S(=O)(=O)c1ccc(C(=O)NCc2cc(Cc3nc4c(ncn4C(CCCc4ccccc4)C(C)=O)c(=O)[nH]3)ccc2OC(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 6/20 0.40
CA12 O43570 5/20 0.40
NPSR1 Q6W5P4 2/20 0.35
TP53 P04637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PDE2A O00408 1/20 0.35
ALDH1A1 P00352 4/20 0.34
USP2 O75604 1/20 0.34
CA1 P00915 4/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
PPARG P37231 7/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
CA2 P00918 1/20 0.32
THRB P10828 1/20 0.32
NCOA2 Q15596 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6024419 0.91 PDE2A (0.33) PDE2APPARA
SCHEMBL6023285 0.89 PDE2A (0.38) PDE2APPARGPPARDPPARA
SCHEMBL6023286 0.84 PDE2A (0.37) PDE2AALDH1A1PPARGPPARDPPARA
SCHEMBL6024621 0.81 PDE2A (0.36) PDE2AALDH1A1MEN1KMT2AMAPT
SCHEMBL6024368 0.79 PDE2A (0.46) TP53PDE2AALDH1A1
SCHEMBL6023491 0.79 PDE2A (0.44) PDE2A
SCHEMBL6024717 0.79 PDE2A (0.46) TP53PDE2AALDH1A1MEN1KMT2A
SCHEMBL6024017 0.78 PDE2A (0.41) NPSR1TP53PDE2AALDH1A1MAPT
SCHEMBL6023455 0.78 PDE2A (0.43) PDE2A
SCHEMBL6024460 0.77 PDE2A (0.38) PDE2AMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106037-A1 Purin-6-one-derivatives ALTANA PHARMA AG (DE) 2006-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106037-A1 Purin-6-one-derivatives PDE4B, PDE4A, PDE2A CA9 4022/4885CA12 4806/4885NPSR1 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.